Because biotechnology has many patent filings and biological sequences are an essential element of the biotic invention, it’s necessary to discuss sequence listing.

What is a Sequence listing?

As biotechnology encompasses gene mutation, gene sequencing, and gene regulation in the domain, antibodies, genetically modified organisms, and biomarkers require the sequencing of genes, amino acids, and nucleotide bases to change the genetic make-up and produce transformed living organisms.

When filing a patent application containing nucleotides and amino acid sequencing, they must all be placed into the patent specification. A specific format or structure must be used for listing instead of the raw form. Sequence listing in patent application refers to the process of putting in these row sequences necessarily according to the Patent Office’s requirements.

Sequence Listing Requirements in Patent Application

  1. All patent filings must follow the regulations of the Patent Office.
  2. All of the filings should be done in a standard format, as the USPTO defines (US CFR 1.821-1.825).
  3. Any unbranched known amino acid sequences with four or more amino acids and all DNA sequences with ten or more nucleotide bases should be listed.
  4. All sequences should be listed, whether expressed in claims or descriptions, but the claims sequence should take precedence.
  5. “SEQ ID NO:” is used in all sequence listings to identify the gene or protein.
  6. Each sequence must have its sequence ID number.

Benefits of Sequence Listing

Genetic sequences are considered both legally and practically important within a patent being filed. This could be in the form of chemical molecules or as data-encoding components. In the context of patent eligibility or infringement difficulties, the sequence structure is significant.

  • To make a single listing that all receiving offices can accept.
  • It helps provide a more detailed description of the sequence.
  • It helps every viewer to access every material in the sequence data easily.
  • Help examiners, candidates to access or find sequence data with ease.
  • Increases the accuracy of amino acids or nucleotide sequences which can be deciphered with ease by the common public.
  • Helps computing sequence data easily in electronic devices and their database.

Key-points to Consider While Filling the Sequences

Following are the essential features that all sequence listings in a patent application must abide by.

  1. Claim sequences should be prioritized, with sequence ID 1 being the first.
  2. The sequence listings should be presented as a separate section of the description, towards the end of the description, and with the heading “Sequence listing.” These listings should start on a separate page with their page numbers.
  3. It is necessary to present the sequences – a Sequence ID NO will help give each sequence its sequence identifier. The sequence identifiers must start with one and increase by integers progressively. For example, SEQ ID NO: 1, then next should be SEQ ID NO: 2, and so on.

The procedure for sequencing might seem easy, but if you own a manufacturing company for medicines, biological components, or skincare, you might want to consider mitigating yourself from the stress involved with listing. It is both time-consuming and tedious, and outsourcing the services to a good sequence listing company can also save you vast expenses of maintaining an in-house team.

If you are considering doing so, then The Sequence Listing Company has got it for you. With their group of experts, the company carefully lists in sequence in the correct format your product’s ingredient list at a very reasonable rate. To know more, avail our services and contact the experts today!.